You are here:   Videos
Register   |  Login

Get Adobe Flash player Install latest flash player if this video gallery doesn't work.
Ganetespib (STA-9090) as Monotherapy in Patients with Advanced NSCLC
From ASCO 2011 – A discussion with Vojo Vukovic, MD, Chief Medical Officer at Synta Pharmaceuticals on the Hsp90 inhibitor ganetespib (STA-9090). Please see a related video with Dr. Geoffrey Shapiro on the open label Phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced NSCLC.
Recent Video
| 
Most Viewed
Tumor Type : Search :